Investigative Profile: Dr Andrew McCombe and His Role in Wellbeing International Foundation

 


Introduction

The newly redesigned website of Wellbeing International Foundation introduces Dr Andrew McCombe, MD as its Medical Director. The site claims he qualified in Edinburgh in 1985, worked for two decades as a Consultant ENT Surgeon at Frimley Park Hospital in the UK, later held senior roles at Mediclinic City Hospital in Dubai, and returned to the UK in 2025.

Our investigation confirms some elements of this biography through independent sources. But other claims remain unverified — and his association with a controversial exosome therapy company raises questions about transparency, oversight, and potential reputational risks.


Verifiable Career Record

  • Frimley Park Hospital, UK:
    Local press reports from 2016 confirm that a consultant ENT surgeon, Dr Andrew McCombe, left Frimley Park after 20 years to take up a post in Dubai. ([Farnham Herald, 2016])

  • Mediclinic City Hospital, Dubai:
    The official Mediclinic Middle East website lists Dr McCombe as a Consultant ENT, trained in Edinburgh, with extensive experience in head and neck surgery. ([Mediclinic.ae])

  • Academic credentials:
    ResearchGate lists ~37 publications under his name, focused on ENT and head/neck surgery, consistent with his claimed specialty.

These records show that Dr McCombe is a real physician with a long-standing ENT career.


What Remains Unclear

  • Medical Director title at Wellbeing International Foundation:
    Public records and medical directories do not list him as a Medical Director of this organisation. The claim is only made on WellbeingInt’s own website.

  • Return to the UK in 2025:
    No evidence has been located in the General Medical Council (GMC) register to show that Dr McCombe currently holds a licence to practise in the UK. This makes the claim of “returning to the UK in 2025” unverifiable at this time.

  • Involvement in exosome therapies:
    Dr McCombe’s known career and publications are in ENT surgery, not regenerative medicine, stem-cell science, or exosomes. There is no public record of him authoring exosome-related trials, regulatory filings, or peer-reviewed studies.

  • Leadership in holistic or regenerative clinics:
    The website references his role as a clinic director at a “holistic polyclinic.” No independent record of this appointment has been found.


Why the Association Matters

The Wellbeing International Foundation markets so-called “cell-free regenerative therapies,” based on exosomes. Regulators including the FDA and MHRA have repeatedly stressed that no exosome products are approved for use in humans outside of trials. Marketing these treatments as ready-to-use carries potential legal and ethical risks.

By appearing as Medical Director of such a clinic, Dr McCombe’s established medical credentials may lend credibility to claims that remain scientifically and legally unsupported. For a physician with a mainstream ENT background, this represents a sharp departure from verifiable expertise.


Key Questions for Dr McCombe

  1. Does Dr McCombe confirm that he holds the title of Medical Director at Wellbeing International Foundation?

  2. Does he currently hold an active GMC licence to practise in the UK?

  3. Has he conducted, overseen, or published any clinical trials involving exosome therapy?

  4. What role, if any, did he play in the design of the treatments marketed on the Wellbeing website?

  5. Has he received compensation for promotional use of his name and biography?

We have sent these questions to Dr McCombe directly and will publish his response in full if received.


Conclusion

Dr Andrew McCombe is a real and experienced ENT surgeon with a verifiable career in the UK and Dubai. However, the Wellbeing International Foundation’s portrayal of him as Medical Director of an exosome therapy company cannot yet be independently confirmed. His direct involvement in regenerative medicine remains undocumented.

Until he provides clarification and regulatory evidence, his name risks being linked to a business that promotes unproven therapies in a regulatory grey zone. For patients and the medical profession alike, transparency is essential.





Comments

Popular posts from this blog

🌍 Global Pattern of Fraud? An Investigative Exposé

Wellbeing International Foundation Ltd Crumbling Under Pressure

Steven Millard: From Victim to Watchdog